1. Home
  2. |Insights
  3. |HOOPS 2014: Legal Flashpoints and Developments

HOOPS 2014: Legal Flashpoints and Developments

Event | 10.27.14 - 10.28.14, 8:00 AM UTC - 1:30 PM UTC

Address

Crowell & Moring
1001 Pennsylvania Avenue, NW, Washington, DC 20004

2014 Healthcare Ounce of Prevention Seminar: Legal Flashpoints and Developments

This year Crowell & Moring's Healthcare Ounce of Prevention Seminar, (HOOPS), will focus on important legal and regulatory developments and their impact on the healthcare industry. Join us in Washington, DC as our healthcare attorneys and outside speakers share their perspectives on the latest developments in areas of interest including:

  • Providers becoming Payors and Payors becoming Providers – Key Legal Considerations
  • False Claims Act and Government Investigations: How to Survive a CID
  • Hot Issues in Payor/Provider Litigation
  • Changing Landscape of Healthcare: A Panel Discussion
  • Focus on Fraud, Waste and Abuse: Audits, Enrollment and Certification
  • Advertising and Marketing Liability
  • Medicare Advantage/Prescription Drug Plan Developments and Changes
  • “Don’t Sign that Yet”: Tools and Tips for Identifying and Avoiding Common Traps in Commercial Contracting.
  • Exchanges, Mental Health Parity and Addiction Equity Act and More
  • Antitrust in an Era of Healthcare Reform
  • New Liability Trends in Data Privacy and Security
  • Recovery Action Scene

HOOPS 2014  is a complimentary event.

CLE credit pending

Please click here for the complete agenda.

For more information, please visit these areas: Corporate and Transactional, Litigation and Trial

Contact

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.